Cardiovascular Disease and Type 2 Diabetes: Defining the Therapeutic Crossroads
Topic:
Cardiovascular Disease and Type 2 Diabetes: Defining the Therapeutic Crossroads
Objectives:
• Explore the relationships between T2D, CVD, and CVD risk factors
• Discuss definitions of primary and secondary prevention of CVD
• Understand current management for comorbidities of T2D and discuss primary and secondary prevention in type 2 diabetes, including long-term oral anti-platelet trials in secondary prevention
Speaker:
Crystal Traylor, MSN, APRN, ANP-C
This webinar is brought to you through a partnership with AstraZeneca.